Skip to main content
    N

    Nexalin Technology Inc. (NXL)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.56
    +0.08 (+5.41%)

    Market Cap: $1.83M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Nexalin Technology Inc. (NXL) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Nexalin Technology (NXL) to earn -$11.42 per share in the fiscal year ending Dec 31, 2026, on revenue of $192000. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$7.55.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 76.0%.

    Fiscal year ending Dec 31, 2026
    -$11.42
    EPS consensus, revenue $192000
    Fiscal year ending Dec 31, 2027
    -$7.55
    EPS consensus, revenue $338000
    Next report
    Mar 23, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$11.42-$11.42 to -$11.421$192000$192000 to $1920001
    Dec 31, 2027-$7.55-$7.55 to -$7.551$338000$338000 to $3380001

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$2.36N/A2$90900$88200 to $945002

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 0 upward and 1 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202601
    Fiscal year ending Dec 31, 202700

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$11.40.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$11.42-$11.40-$11.40-$11.40-$11.40N/A
    Fiscal year ending Dec 31, 2027-$7.55-$9.30-$9.30-$9.30-$9.30N/A

    Frequently Asked Questions About NXL

    What is the NXL stock forecast?

    Consensus analyst estimates put Nexalin Technology's EPS at -$11.42 for the fiscal year ending Dec 31, 2026, on revenue of $192000.

    What EPS do analysts expect from NXL next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$11.42, with estimates from -$11.42 to -$11.42 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$7.55, with estimates from -$7.55 to -$7.55 from 1 analyst.

    What revenue do analysts expect from Nexalin Technology next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $192000, with estimates from $192000 to $192000. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $338000, with estimates from $338000 to $338000.

    How many analysts cover NXL?

    1 analyst estimates EPS for Nexalin Technology for the fiscal year ending Dec 31, 2026.